Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning

BACKGROUND: Genome-scale metabolic models (GEMs) offer insights into cancer metabolism and have been used to identify potential biomarkers and drug targets. Drug repositioning is a time- and cost-effective method of drug discovery that can be applied together with GEMs for effective cancer treatment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:EBioMedicine
Asıl Yazarlar: Turanli, Beste, Zhang, Cheng, Kim, Woonghee, Benfeitas, Rui, Uhlen, Mathias, Arga, Kazim Yalcin, Mardinoglu, Adil
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2019
Konular:
Research paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491384/
https://ncbi.nlm.nih.gov/pubmed/30905848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.03.009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller